Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$4.98 USD
+0.29 (6.18%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $4.98 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value C Growth F Momentum D VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Collaborative Arrangements Revenue: Linaclotide Collaboration & License Agreements - AbbVie (North America)
- 433.24
- 401.50
- 403.09
- 370.90
- --
- Revenue - Line of Business (LOBR)
- Collaborative Arrangements Revenue: Linaclotide Collaboration & License Agreements - AbbVie (Europe & Other)
- 2.78
- 2.44
- 2.56
- 2.20
- --
- Revenue - Line of Business (LOBR)
- Collaborative Arrangements Revenue: Linaclotide Collaboration & License Agreements - AstraZeneca (China, Including Hong Kong & Macau)
- 0.43
- 0.64
- 0.74
- 0.68
- --
- Revenue - Line of Business (LOBR)
- Collaborative Arrangements Revenue: Linaclotide Collaboration & License Agreements - Astellas (Japan)
- 1.80
- 2.00
- 2.23
- 2.13
- --
- Revenue - Line of Business (LOBR)
- Collaborative Arrangements Revenue: Other Agreements: Other
- 2.48
- 1.82
- 1.76
- 1.34
- --